Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS)
- PMID: 21521206
- DOI: 10.1111/j.1526-4610.2011.01885.x
Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS)
Abstract
Objective: To estimate the prevalence of chronic migraine (CM) among adolescents and to describe the epidemiologic profile, headache characteristics, disability, and healthcare utilization of adolescents with CM in the USA.
Background: Chronic daily headache (CDH) and CM occur in children and adolescents, but are poorly understood in these populations because their presentation is different from that in adults. It may be difficult to assign a definitive diagnosis to young people suffering from CDH because symptoms may fail to meet the criteria for one of the CDH subtypes.
Methods: A large sample of households with at least one resident aged 12 to 19 years was selected in balance with the US Census. Data were collected in 3 phases: (1) mailed questionnaire; (2) telephone interview; and (3) 30-day interactive voice response system diary. CM prevalence was estimated by adapting the second edition of the International Classification of Headache Disorders criteria for CM to include pediatric migraine diagnostic criteria. The population was stratified for medication overuse. Medication overuse was defined as 15 or more days per month of acute medication use. Included in the study were measures of headache characteristics, headache impact (Headache Impact Test), disability (Pediatric Migraine Disability Assessment), and healthcare and medication use. Data are reported on subjects 12 to 17 years of age only.
Results: The US adolescent (12-17 years) prevalence rate for CM was 0.79% (0.00-1.70) excluding those with medication overuse and 1.75% (0.62-2.89) when adolescents with medication overuse were included. The majority of adolescents with CM had Headache Impact Test scores greater than or equal to 60, indicating severe headache impact, and mean Pediatric Migraine Disability Assessment scores greater than 17, indicating severe headache and disability. The majority of adolescents with CM (approximately 60%) had not visited a healthcare provider in the previous year and less than one in 5 reported taking medications to prevent headaches during the last month.
Conclusions: Results suggest that CM occurs less frequently in adolescents than adults, but like adults, adolescents are severely burdened by the disorder. Data support an unmet medical need; however, the development of optimal criteria for diagnosing adolescents with CM is critical to fully understanding how medical needs can be met within this complex population.
© 2011 American Headache Society.
Similar articles
-
Migraine: epidemiology, impact, and risk factors for progression.Headache. 2005 Apr;45 Suppl 1:S3-S13. doi: 10.1111/j.1526-4610.2005.4501001.x. Headache. 2005. PMID: 15833088 Review.
-
Headache disability among adolescents: a student population-based study.Headache. 2010 Feb;50(2):210-8. doi: 10.1111/j.1526-4610.2009.01531.x. Epub 2009 Oct 5. Headache. 2010. PMID: 19804389
-
Impact of comorbidity on headache-related disability.Neurology. 2008 Feb 12;70(7):538-47. doi: 10.1212/01.wnl.0000297192.84581.21. Neurology. 2008. PMID: 18268246
-
Pain among children and adolescents: restrictions in daily living and triggering factors.Pediatrics. 2005 Feb;115(2):e152-62. doi: 10.1542/peds.2004-0682. Pediatrics. 2005. PMID: 15687423
-
The epidemiology, burden, and comorbidities of migraine.Neurol Clin. 2009 May;27(2):321-34. doi: 10.1016/j.ncl.2008.11.011. Neurol Clin. 2009. PMID: 19289218 Review.
Cited by
-
Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?Pediatric Health Med Ther. 2022 Sep 9;13:309-323. doi: 10.2147/PHMT.S334744. eCollection 2022. Pediatric Health Med Ther. 2022. PMID: 36110896 Free PMC article. Review.
-
Epidemiology of migraine and headache in children and adolescents.Curr Pain Headache Rep. 2013 Jun;17(6):341. doi: 10.1007/s11916-013-0341-z. Curr Pain Headache Rep. 2013. PMID: 23700075 Review.
-
Diagnosis and Treatment of Childhood Migraine.Curr Treat Options Neurol. 2016 Nov;18(11):48. doi: 10.1007/s11940-016-0431-4. Curr Treat Options Neurol. 2016. PMID: 27704257 Review.
-
A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine.Headache. 2020 Mar;60(3):564-575. doi: 10.1111/head.13754. Epub 2020 Feb 9. Headache. 2020. PMID: 32037549 Free PMC article. Clinical Trial.
-
Medication-overuse headache: a widely recognized entity amidst ongoing debate.J Headache Pain. 2018 Jul 13;19(1):50. doi: 10.1186/s10194-018-0875-x. J Headache Pain. 2018. PMID: 30003412 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous